You are here

Home

Biblio

Journal Article
Baker E, Sims R, Leonenko G, Frizzati A, Harwood JC, Grozeva D, Morgan K, Passmore P, Holmes C, Powell J et al..  2019.  Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.. PLoS One. 14(7):e0218111.
Pillai JA, Bebek G, Khrestian M, Bena J, Bergmann CC, Bush WS, Leverenz JB, Bekris LM.  2021.  Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease.. Front Aging Neurosci. 13:638922.
Ibañez L, Bahena JA, Yang C, Dube U, Farias FHG, Budde JP, Bergmann K, Brenner-Webster C, Morris JC, Perrin RJ et al..  2020.  Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease.. Acta Neuropathol Commun. 8(1):196.
Butkiewicz M, Blue EE, Leung YYee, Jian X, Marcora E, Renton AE, Kuzma A, San Wang L-, Koboldt DC, Haines JL et al..  2018.  Functional annotation of genomic variants in studies of late-onset Alzheimer's disease.. Bioinformatics. 34(16):2724-2731.
Vance E, Murcia JDGonzalez, Miller JB, Staley L, Crane PK, Mukherjee S, Kauwe JSK.  2020.  Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.. Neurobiol Aging. 89:142.e9-142.e12.
Martin ER, Gao XR, Li Y-J.  2021.  An exploration of genetic association tests for disease risk and age at onset.. Genet Epidemiol. 45(3):249-279.
Wang Y, Chen H, Peloso GM, DeStefano AL, Dupuis J.  2021.  Exploiting family history in aggregation unit-based genetic association tests.. Eur J Hum Genet.
Jian X, Satizabal CL, Smith AV, Wittfeld K, Bis JC, Smith JA, Hsu F-C, Nho K, Hofer E, Hagenaars SP et al..  2018.  Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging.. Stroke. 49(8):1812-1819.
Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J et al..  2020.  Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.. Nat Commun. 11(1):667.
Olive C, Ibañez L, Farias FHGeraldo, Wang F, Budde JP, Norton JB, Gentsch J, Morris JC, Li Z, Dube U et al..  2020.  Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.. J Alzheimers Dis. 77(4):1469-1482.
Fernández MV, Budde J, Del-Aguila JL, Ibañez L, Deming Y, Harari O, Norton J, Morris JC, Goate AM, Cruchaga C.  2018.  Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease.. Front Neurosci. 12:209.
Bressler J, Marioni RE, Walker RM, Xia R, Gottesman RF, B Windham G, Grove ML, Guan W, Pankow JS, Evans KL et al..  2019.  Epigenetic Age Acceleration and Cognitive Function in African-American Adults in Midlife: The Atherosclerosis Risk in Communities Study.. J Gerontol A Biol Sci Med Sci.
Avila JF, Rentería MArce, Jones RN, Vonk JMJ, Turney I, Sol K, Seblova D, Arias F, Hill-Jarrett T, Levy S-A et al..  2021.  Education differentially contributes to cognitive reserve across racial/ethnic groups.. Alzheimers Dement. 17(1):70-80.
Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C.  2021.  Early-Onset Alzheimer's Disease: What Is Missing in Research? Curr Neurol Neurosci Rep. 21(2):4.
Marca-Ysabel MVictoria, Rajabli F, Cornejo-Olivas M, Whitehead PG, Hofmann NK, Manrique MZaida Illa, Otani DMartin Vel, Neyra AKarina Mil, Suarez SCastro, Vega MMeza et al..  2021.  Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population.. Neurobiol Aging. 101:298.e11-298.e15.
Broce IJ, Tan CHong, Fan CChieh, Jansen I, Savage JE, Witoelar A, Wen N, Hess CP, Dillon WP, Glastonbury CM et al..  2019.  Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.. Acta Neuropathol. 137(2):209-226.
Vardarajan B, Kalia V, Manly J, Brickman A, Reyes-Dumeyer D, Lantigua R, Ionita-Laza I, Jones DP, Miller GW, Mayeux R.  2020.  Differences in plasma metabolites related to Alzheimer's disease, ε4 status, and ethnicity.. Alzheimers Dement (N Y). 6(1):e12025.
Lee J, Khobragade PY, Banerjee J, Chien S, Angrisani M, Perianayagam A, Bloom DE, Dey AB.  2020.  Design and Methodology of the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (LASI-DAD).. J Am Geriatr Soc. 68 Suppl 3:S5-S10.
Laverde-Paz MJuliana, Nuytemans K, Wang L, Vance JM, Pericak-Vance MA, Dykxhoorn DM, Cukier HN.  2021.  Derivation of stem cell line UMi028-A-2 containing a CRISPR/Cas9 induced Alzheimer's disease risk variant p.S1038C in the TTC3 gene.. Stem Cell Res. 52:102258.
Akinyemi RO, Yaria J, Ojagbemi A, Guerchet M, Okubadejo N, Njamnshi AK, Sarfo FS, Akpalu A, Ogbole G, Ayantayo T et al..  2021.  Dementia in Africa: Current evidence, knowledge gaps, and future directions.. Alzheimers Dement.
Jo T, Nho K, Risacher SL, Saykin AJ.  2020.  Deep learning detection of informative features in tau PET for Alzheimer's disease classification.. BMC Bioinformatics. 21(Suppl 21):496.
De Jager PL.  2021.  Deconstructing the epigenomic architecture of human neurodegeneration.. Neurobiol Dis. 153:105331.
Kuksa PP, Amlie-Wolf A, Katanić Ž, Valladares O, San Wang L-, Leung YYee.  2019.  DASHR 2.0: integrated database of human small non-coding RNA genes and mature products.. Bioinformatics. 35(6):1033-1039.
Ouellette AR, Neuner SM, Dumitrescu L, Anderson LC, Gatti DM, Mahoney ER, Bubier JA, Churchill G, Peters L, Huentelman MJ et al..  2020.  Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia.. Cell Rep. 32(9):108091.
Keys KL, C Y Mak A, White MJ, Eckalbar WL, Dahl AW, Mefford J, Mikhaylova AV, Contreras MG, Elhawary JR, Eng C et al..  2020.  On the cross-population generalizability of gene expression prediction models.. PLoS Genet. 16(8):e1008927.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer